Poster Number Proposal Name First Name Last name
Day 1      
ASD 1 Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer: the UCSF Prostate Cancer Genetic Testing Station. Fern Alagala
ASD 2 COVID workflow adjustments impact where, when, and how genetic counseling was delivered early in the pandemic Cary Armstrong
ASD 3 Family History Collection, Genetic Risk Assessment, and Use of Digital Health Tools by Obstetricians Hitashi Bansal
ASD 4 Utilization of Genetics Services in the Diagnosis of Hearing Loss in Newborns in the State of Ohio Cara Barnett
ASD 5 Genomic Testing in Healthy Individuals: The Brigham Preventive Genomics Clinic Tala Berro
ASD 6 "It's the same as if you did meet them in person" The Genetic Patient's Perspective on Telehealth Consultations Emily Bonnell
ASD 7 One Cancer Genetic Counseling Clinic’s Response to COVID-19: ‘Ghost Protocol’ Christine Bruha Steele
ASD 8 Evaluation of Family Group Telehealth Genetic Counseling Services Natasha Chadburn
ASD 9 Genetic counseling in the inpatient care setting: genetic counselors perceive that on-demand services are valuable to patients and providers Cheyla Clark
ASD 10 Integration of universal genetic counseling and testing for newly diagnosed breast cancer patients Julie O. Culver
ASD 11 Genetic Counselor Perceptions of Patient Outcomes from Non-Genetics Providers Offering Genetic Services Katharine Drum
ASD 12 Implementation and Evaluation of a Genetic Services Referral Phone Line in the New York-Mid-Atlantic Consortium (NYMAC) Region Alyson E. Evans, MS
ASD 13 How Much We Tell Our Patients: Counseling Differences between Genetic Counselors and Other Providers Jessica Feldman
ASD 14 Patient satisfaction with direct telegenetic counseling for prenatal compared to hereditary cancer indications Kristi Fissell
ASD 15 Perceptions of Genetic Counseling and Testing in the Haitian Patient Population Elizabeth Francisco
ASD 16 Delivering Bad News in Genetic Counseling via Telephone: Evaluating Distress, Perceived Personal Control, and Satisfaction in Patients Allison Gossen
ASD 17 “You’re in charge of your health”: Perspectives of hereditary cancer population screening participants Veronica Greve
ASD 18 Comparing Clinician-Parent Communication Patterns During Genome Sequencing Result Disclosures in a NICU Setting Brittany Griffin
ASD 19 Satisfaction with online pre-test education, at-home BRCA screening, and telehealth genetic counseling in the Ashkenazi Jewish population: an Atlanta pilot study Melanie W. Hardy, MS, MS, CGC
ASD 20 Assessment of Understanding and Satisfaction of Clinical Exome Sequencing (ES): Video Consent vs Telephone Consent Hannah Helber
ASD 21 A Novel Genetic Testing Reminder System Using an Online Signature Platform Sayoni Lahiri
ASD 22 Extending the Reach of Cancer Genetic Counseling to the Safety Net: Effectiveness of Genetic Counseling across Three Modes of Delivery Robin Lee
ASD 23 Characterization of Genetic Counselor Practices in Inpatient Care Settings Emily Magness
ASD 24 The Innovative Use of RedCap as a Means to Recontact Patients with Hereditary Cancer Caitlin Mauer
ASD 25 Telegenetics vs. In-Person Satellite Clinic- Patient acceptance and effect on access and adherence Ryan Noss
ASD 26 Exploring South Asian Perspectives on Genetic Counseling Shabri Patel
ASD 28 Patient satisfaction with Genetic Results Counseling service Ellen Schlenker
ASD 29 Characterization of genetic counseling follow-up decisions among patients with a medically actionable result from genomic screening Marci Schwartz
ASD 30 Exploring perceptions and attitudes towards integrating a genetic counselor into a multidisciplinary primary care practice team. A qualitative GenCOUNSEL study Caitlin Slomp
ASD 31 Genetic counselors leveraging technology: Integrating telemedicine into general genetics clinic via pre-clinic screening Christine Spaeth
ASD 32 Inherited Retinal Degeneration Current Genetics Practices – A Needs Assessment Sydney Strait
ASD 33 Custom automated software tools increase genetic counseling follow-up task efficiency Kelly Tangney
ASD 34 Adapting Genetic Testing Results Disclosures to Patient Preferences at the Prostate Cancer Genetic Testing Station Barry Tong
ASD 35 Should All Patients with Breast Cancer be Offered Genetic Testing? Reactions to the ASBrS Consensus Guideline on Genetic Testing for Hereditary Breast Cancer Kelly Tripi
ASD 36 Impact of a GCA on genetic counselor efficiency in a cancer genetics clinic Meghan Vanwanzeele
ASD 37 How Do Genetic Counselors and Genetic Counseling Assistants Spend Their Time? A Workflow Analysis Siddika Venkatachalam
ASD 38 Barriers Remaining After the Integration of Genetic Counseling in a Multi-Disciplinary Pancreatic Cancer Clinic Elise Watson
ASD 39 A Snapshot of Consumer-Initiated Genetic Testing: A Demographic Chart Review Nori Williams
ASD 40 Motivations For Ordering Consumer-Initiated Genetic Testing: A Chart Review Nori Williams, CGC
ASD 41 Refining a Tool to Automate Portions of Pre-Test Genetic Counseling for Inherited Cancer Brenda Zuniga
ADT 42 Familial Partial Lipodystrophy Type 2 and 3 due to Likely Pathogenic LMNA and PPARG Variants Identified in Two Individuals with Atypical Presentations Colby Chase
ADT 43 DTC Ancestry Testing Reveals a 46,XX Male and Infertility Kelly East
ADT 44 Identification of a pathogenic MECP2 variant in two adults presenting to a Medical Genetics clinic with intellectual disability Anna Raper, MS, CGC
ADT 45 The Perspective of Men with Barth Syndrome: Relationship Building, Family Planning, and Reproductive Decision-Making Jason Shandler
ADT 46 eMERGE Consortium Participant Reported Sharing of Genomic Screening Results with Family Members. Julia Wynn
CAN 47 CTNNA1 Reclassified From Pathogenic To a Variant of Unknown Significance In a Breast Cancer Patient: Managing Patient and Counselor Expectations Dina Alaeddin
CAN 48 Somatic Tumor Testing Implications for Lynch Syndrome Germline Genetic Testing Kathleen Barrus
CAN 49 Breast cancer in PMS2-positive patients Kylin Boehler
CAN 50 Positive Patient BRCA1/2 Direct-to-Consumer Genetic Testing Results: Now What? Sarah Burke
CAN 51 Case of BRCA Double Heterozygosity in a Non-Ashkenazi Jewish Individual Cara Cacioppo
CAN 52 Utilization of broad approaches of genetic counseling and testing to better understand pediatric cancer predisposition Katie Church
CAN 53 Risk Reducing Mastectomies among Women with Mutations in Moderate Penetrance Breast Cancer Susceptibility Genes Jacob Comeaux
CAN 54 Reported Phenotype in Individuals with NF1 Pathogenic Variants Identified by Panel Testing Lauren Currie
CAN 55 Trends in Ordering Patterns of Hereditary Cancer Panels Lauren Currie
CAN 56 A novel case of lobular breast cancer in a male patient with a pathogenic mutation in CDH1 Matthew Emery
CAN 57 Co-occurrence of attenuated familial adenomatous polyposis (AFAP) and Lynch syndrome: A case report with implications for surveillance. Jamie Fisher
CAN 58 Genetic counselors’ use of multi-gene panels in cancer genetics: A quantitative study Natasha Fuller
CAN 59 Expanding Phenotypes for Male BARD1 Carriers: A Case Report Melissa Gandhi
CAN 60 Discrepant CDKN2A c.146T>C variant: a clinical experience Amber Gemmell
CAN 61 Motivations for Pursuing Genetic Counseling to Explore the Availability of Panel Genetic Testing Jessalyn Gerber
CAN 62 Toward a Better Understanding of the Experience of Patients with Moderate Penetrance Breast Cancer Gene Mutations: A focus on ATM and CHEK2 Carly Grant
CAN 63 Who would have been missed? A comparison of current and past hereditary cancer testing guidelines in a large prospective universal testing study Megan Hager
CAN 64 Pathogenic variant classifications are not always well-supported by evidence Sarah M. Hamilton
CAN 65 An Extended Case Series of Gastrointestinal Neoplasms in Li-Fraumeni Syndrome Jessica Hatton
CAN 66 Families with Rare POT1 Variants Identified Through Multigene Panel Testing Marie-Louise Henry
CAN 67 Implementation of Hereditary Genetic Testing for All Patients with a Personal History of Breast Cancer: Perspectives of Key Healthcare Professionals Kyle Heraty
CAN 68 Melanoma Risk in POT1 Mutation Carriers from a MGPT Cohort Jennifer Herrera-mullar
CAN 69 Site-Specific Analysis vs. Multi-Gene Panel Testing for Familial Cancer Variants: Current Practices of Genetic Counselors Eleanor Hilton
CAN 70 Review Process of Somatic Tumor Reports for Genetic Counseling Referrals Brenda Ho
CAN 71 De novo TP53 variant in a child with early onset rhabdomyosarcoma and maternal history of gestational choriocarcinoma Sarah E Jennings
CAN 72 Attitudes and Practices of Genetic Counselors towards Hereditary Cancer Syndromes with Associations of Unclear or Conflicting Evidence Kerry Johnson
CAN 73 Evaluation of Pilot Program to Implement Breast Cancer Risk Assessment at Screening Mammography in One US Health System Alanna Kulchak Rahm
CAN 74 Expanding the detection range of DNA multigene panel testing with concurrent RNA sequencing Holly LaDuca
CAN 75 An Interpretative Phenomenological Analysis: The Lived Experience of Emerging Adults at Risk for Gastric Cancer Due to a CDH1 Variant in Medical Management Decision Making Yi Liu
CAN 76 Real-world Multi-Country Study of Germline BRCA1/2 Mutation (gBRCA1/2mut) Testing and Genetic Counseling (GC) Among Patients (pts) With Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) Reshma Mahtani
CAN 77 Inconclusive genetic test results and a phenotype possibly confounded by prior childhood cancer Rachelle Manookian
CAN 78 Double heterozygosity for RET and PTEN: one family’s phenotype Nicole Mans
CAN 79 A case report of an incidental germline AXIN2 likely pathogenic variant in a patient with ovarian cancer Kimberly Matthijssen
CAN 80 Development and Initial Outcomes of a Hereditary Hematologic Malignancies Clinic Kelsey Moriarty
CAN 81 A case of an infant with Beckwith Wiedemann syndrome and Marfan syndrome: The value of taking a family history Alise Murray
CAN 82 An unexpected diagnosis of MUTYH-associated polyposis: A case study Honey Nagakura
CAN 83 Comprehensive germline multigene panels change clinical care and inform treatment strategies for breast cancer patients Sarah M Nielsen
CAN 84 Genetic Counselors’ Attitudes and Practices Regarding Preimplantation Genetic Testing for Hereditary Breast and Ovarian Cancer Hannah Novak
CAN 85 Sources of Community Referrals to a Pediatric Cancer Predisposition Clinic: Opportunities for Outreach Regina Nuccio, MS, CGC
CAN 87 Genetic Counseling (GC) Patterns by Practice Setting Among Patients (pts) With Germline BRCA1/2 Mutated (gBRCA1/2mut) Advanced Breast Cancer (ABC): Results From a US Retrospective Medical Records Review Study Elias Obeid
CAN 88 A Process Improvement Analysis of Referral Rates to Genetic Counseling for Consideration of Germline Genetic Testing After Receipt of Somatic Genetic Testing Results Rachel Paul
CAN 89 BRIP1: An institutional experience with a dynamic gene Sara Pirzadeh-Miller
CAN 90 “I wish that there was more info”: Characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants Kathryn Reyes
CAN 91 Exploring Current Practices and Perspectives of Genetic Counselors on DNA Biobanking in Oncology Hillary Rieger
CAN 92 A Qualitative Study of Transgender Patients’ Perspectives on their Cancer Genetic Counseling Experiences Lathel Rolle
CAN 93 Impact of Genetic Based Melanoma Risk Assessment on Attitudes and Preventative Behaviors Kaylee Ruiz
CAN 94 An Analysis of the Lived Experience of Patients Incidentally Found to Carry a Pathogenic TP53 Mutation Emily Seckington
CAN 95 Rapid Adaptation and Evaluation of a Telemedicine-Only Cancer Genetic Counseling Model in the COVID-19 Pandemic Margaret Sheehan
CAN 96 A Postmortem End to the Diagnostic Odyssey: The Diagnosis of Noonan Syndrome in a Boy with ALL and Secondary T-Lymphoblastic Lymphoma Susan Shehayeb
CAN 97 Psychosocial Outcomes Following An Abnormal ctDNA-Based Cancer Screening Test Gabrielle T. Shermanski, MS
CAN 98 Provider Experiences with Incidental Germline Findings Revealed Through Somatic Sequencing in Oncology Ilana Solomon
CAN 99 The Impact of the “American Society of Breast Surgeon’s 2019 Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer” on Cancer Genetic Counselors Jillian Tokarczyk
CAN 100 Germline pathogenic/likely pathogenic variant incidence in individuals with colorectal cancer stratified by age at diagnosis Natalie Tri
CAN 101 Atypical genetic causes of Lynch syndrome: a case series Magan Trottier
CAN 102 Frequency of 5 Cancer Types in Families with a Pathogenic or Likely Pathogenic Variant in the ATM Gene Diana Moglia Tully
CAN 103 Mosaic STK11 Mutation in the Context of a Clinical Diagnosis of Peutz-Jeghers Syndrome (PJS) and Ashkenazi Jewish Ancestry: Genetic Counseling Opportunities and Challenges Morgan Turner, MS, CGC
CAN 104 Clinical Presentation of Individuals with Pathogenic/Likely Pathogenic TP53 Variants Detected via Different Ascertainment Methods: a Case Series Julia Weston
CAN 105 Factors in Screen Adherence Across the Lifespan in Individuals with Rare Hereditary Cancer Syndromes Amy Whitburn
CAN 106 The Phenotype of POT1 Pathogenic Variant Carriers Elizabeth Wiley
CAN 107 Early-onset triple negative breast cancer for a family with a likely pathogenic RAD51C mutation: considerations for improved screening and surveillance Edward Williams
CAN 108 From Business Plan to a Three-Year Implementation Review: Successes/Challenges for the solo genetic counseling establishing hereditary cancer risk assessment and risk education Edward Williams
CAN 109 A pilot study of breast cancer polygenic risk scores shows discrepancies between laboratories. Julia Wynn
CAN 110 Neuroblastoma and Cutaneous Angiosarcoma in a Child with PTEN Hamartoma Tumor Syndrome Kristin Zelley
CAN 111 Evaluation of Genetic Counseling Referral Rates Before and After Inclusion of Genetic Counselor Attendance at Gynecologic Oncology Tumor Board Marie Zerjav
CAR 113 What Makes at-risk Family Members Pursue Cascade Genetic Testing for Hypertrophic Cardiomyopathy? Emily Callahan
CAR 114 Development of Death Investigator Education on Genetics and Postmortem Genetic Testing - A Pilot Study Rachel Campagna
CAR 115 Risk perception and screening behaviors in individuals with an inherited predisposition for Hypertrophic Cardiomyopathy Melanie Emmerson
CAR 116 Exploring the Communication of Cardiac-Related Risk to First-Degree Relatives After the Sudden Death of a Young Family Member Martha Francoeur
CAR 117 Genetic counseling for bicuspid aortic valve: Predictors of knowledge, empowerment, and familial uptake of cardiac screening Bailey Hancock
CAR 118 Comprehensive Analysis of Cardiomyopathy and Arrhythmia Genes Yields Unanticipated Molecular Diagnoses Ana Morales
CAR 119 Exploring Lab vs. Clinical Discrepancies in Five Genes Known to Cause Loeys-Dietz Syndrome Mitchel Pariani
CAR 120 Investigating Medical Examiners’ Practices: Genetic Evaluation for Fatal Acute Aortic Dissection Bradley Power
CAR 121 Pediatric Primary Care Providers Use of And Adherence to Cholesterol Screening Guidelines When Assessing Patients For Hypercholesterolemia: A Qualitative Assessment of Providers In Minnesota And California Jenna Soukup
CAR 122 Applying Motivational Interviewing Strategies with the Extended Parallel Process Model to Improve Risk Communication for Parents of Children with Familial Hypercholesterolemia Bridget Winchester
CAR 123 Outcomes from a Novel Genetic Counseling Intervention Using Motivational Interviewing and The Extended Parallel Process Model to Increase Cascade Cholesterol Screening Heather Zierhut
CPI 124 Exploration of Patient Attitudes toward Receiving Incidental Diagnoses of Lysosomal Storage Disorders Through Expanded Carrier Screening Allison Abbott
CPI 125 Getting punched in the gut – The experience of families receiving a negative genome-wide sequencing result Shelin Adam, MSc
CPI 126 The Impact of Hindu Philosophy on Perspectives of Hindu Women on Pregnancy Termination Amanda Back
CPI 127 Depression Screening Practices of Prenatal Genetic Counselors Sarah Belsky
CPI 128 Time well spent: Lessons learned from a qualitative study exploring parental reactions to genetic counseling patient letters after a pediatric visit Courtney Brown
CPI 129 Decision-Making in Mental Health Referral: The Influence of Genetic Counselor Emotion Hannah Campbell
CPI 130 Discordant Interpretations of Germline Variants in Hereditary Cancer - A Psychosocial Burden? Meera Clytone
CPI 131 Simpatía y Respeto: Spanish speaking genetic counselors’ perceptions of language concordance in genetic counseling sessions Amanda de Leon
CPI 132 Proxy Patient's Perceptions of Genetic Counselor's Empathy Responses Jennine Deckert
CPI 133 Calculating and Communicating Error Estimates For Pathogenic Variant Classifications Julie M. Eggington
CPI 134 An Exploration of the Psychosocial Impact of Gene Therapy for Individuals with Hemophilia Haley Fischman
CPI 135 Experiences and Perspectives of Patients who Have Considered or Undergone Transfer of Embryos with Mosaic PGT-A Results Eva Gabor-Fourcade
CPI 136 Genetic counselors' practices and perceptions when counseling native clients Hannah Garn
CPI 137 Investigating factors that influence genetic counselors’ decisions to refer patients to mental health providers Taylor Hayes
CPI 138 Use of NCCN Distress Thermometer in Cancer Genetics Patients Michelle F. Jacobs
CPI 139 Hispanic Patients’ Perspectives on Language-Concordant Cancer Genetic Counseling Sessions Sharisse Jimenez
CPI 140 Characterizing the Mental Health Referral Process in Genetic Counseling Colleen Jodarski
CPI 141 Are genetic counselors prepared to counsel active-duty service members? Michael Kamen
CPI 142 Review of patients who actively decline recommended CIT post-test genetic counseling Robin King
CPI 143 Psychological Distress in Response to Physical Activity Restrictions in Patients with Non-syndromic Thoracic Aortic Aneurysm/Dissection Alexis McEntire
CPI 144 Exploring the impact of empathy-based practice on a genetic counselor’s emotional state during their pregnancy Emma Moores
CPI 145 From bookbags to company cars: A window into the experiences of growing up with an undiagnosed medical condition Christina Pool
CPI 146 The Psychosocial Impact of Having a Child with Usher Syndrome: What Can be Done to Better Meet the Needs of Parents and Caregivers Rachel Rabenn
CPI 147 Issues of countertransference in providing reproductive genetic counseling for a patient with SMA type II Jill Slamon
CPI 148 Genetic Testing and Counseling for Asian Americans: A Systematic Review Jennifer Young
EDU 149 Graduate Training Experiences of Genetic Counseling Students in the United States and Canada Pauline Aamodt
EDU 150 Genetic Counseling Graduate Programs: Is a Standardized Application Possible? Erin Beasley, BA
EDU 151 Bayes for Days: Development of a Case-Based Risk Assessment Course for Genetic Counselors Grace Bronken, MS
EDU 152 Genetics Knowledge of Patients with Hereditary TTR Amyloidosis Emily Brown
EDU 153 Group Meditation, Addressing Stigma, and ‘Mental Health Days’: Recommendations for Integrating Self-Awareness Practices into Genetic Counseling Graduate Programs Laura Bulmer, MS
EDU 154 Impact of Medical Improv Training on Preparation Genetic Counseling Assistants for Graduate School Interviews Remington Fenter
EDU 155 Exploring the Impact of a Variant Curation Module in the Undergraduate Classroom Kassandra Grimm
EDU 156 Creating and Evaluating a Tool to Support Families Receiving Genomic Testing Results Julia Handra
EDU 157 Two Cycles In: Investigating Admissions Committee Members’ Perspective on the Genetic Counseling Match Eileen Hoffman
EDU 158 Genetic Counseling Assistant-Run Clinic: Enhancing Prospective Genetic Counselors’ Skill Sets and Improving Clinic Efficiencies Caitlin Mauer
EDU 159 Digital peer-to-peer sharing: Online opportunities for NBS education Brianne Miller
EDU 160 Podcast Development to Train Genetic Counseling Clinical Supervisors: A Pilot Study Rebecca Padersky
EDU 161 Exploring Genetic Counseling Students' Experiences with the Job Search and the Impact of Clinical Training Haewon Park
EDU 162 Development of a Graduate Certificate in Genomics for Genetic Counselors at UBC Anastasia Richardson
EDU 163 Assessing the training of current genetic counseling students related to pharmacogenomic testing Daniel Serber
EDU 164 Are Genetic Counseling Graduates Prepared to Counsel on Health Insurance Coverage and Costs of Genetic Testing? Hannah Sigurdson
EDU 165 Anger, Fear, and Sadness: Differences in Genetic Counseling Student Responses to Intense Patient Affect Rachel Simon
EDU 166 Assessing the Current State of Affairs Surrounding Education on Counseling Direct-to-Consumer Testing Patients Through Surveying Genetic Counseling Program Directors Erin Swartz
EDU 167 Pharmacogenetics and Direct-to-Consumer Testing: A Knowledge Gap in the Genetic Counseling Community Alora Terry, MS, GC
EDU 168 The Development of a Telehealth Rotation in Response to Program Needs Shannon Wieloch
EDU 169 Genetic Counseling Student Remote Rotation in ClinGen Variant Interpretation: Expanding Training Options Diane Zastrow
ELS 170 Defining the Critical Components of Informed Consent for Genetic Testing Maia Borensztein
ELS 171 Increasing recruitment of patients with undiagnosed diseases from underserved populations in the Pacific Northwest Brenna Boyd
ELS 172 Impact of Psychiatric Genetic Data on Tort Litigation and its Relationship with Stigma Kira Dineen, MS, GC, CG(ASCP)CM
ELS 173 Understanding genetic counselors' perceptions of a duty to warn Alexis Lash
ELS 174 Impact of ancestry-related test limitations on informed consent and pre-test genetic counseling Joseph Liu
ELS 175 Ethical Considerations for X-ALD Screen-Positive Females on State Newborn Screening Claire Newman, MS, CGC
ELS 176 The Role of GenomeConnect in Keeping Patients Updated about their Genetic Test Results Juliann M. Savatt
ELS 177 A Family Dilemma: Ethical Considerations While Coordinating Familial Testing for an Inherited Telomere Biology Disorder Lindsey Schmidt
ELS 178 Genetic Counseling Students and Recent Graduates’ Opinions about Abortion Courtney Schuiteman
ELS 179 Knowledge and Attitudes About Privacy and Secondary Data Use Among African Americans Consumers Using Direct-to-Consumer Genetic Testing Emily Ziegler
Day 2      
GGT 180 Post Mortem Genetic Testing in Sudden Unexpected Death in Epilepsy [SUDEP]: A Pilot Study Yu An
GGT 181 Clinically Actionable Findings Derived from Predictive Genomic Testing Offered in a Medical Practice Setting Jennifer Anderson, MS, LCGC
GGT 182 Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in the United States Ramesh Arjunji
GGT 183 Mitochondrial Replacement Therapy: Genetic Counselors’ Experiences, Knowledge and Opinions Anjali Aryamvally
GGT 184 The Role of Genetic Counseling Self-Efficacy in Variant Interpretation Discrepancies Brenna Bentley
GGT 185 Preimplantation Genetic Testing: Indications for use and characteristics of users over 8 years at a single institution Megan Bunnell, MD, MS GCG
GGT 186 Improving Exome Sequencing Diagnostic Rate by Investigation of Unsolved Cases Caitlin Chisholm
GGT 187 Tools for Genetic Counseling Sessions with Direct to Consumer Genetic Testing Clients Allison Costa, BS, BA
GGT 188 Adopted Individuals’ Interest in Elective Genomic Testing Jessica Edgar
GGT 189 Making somatic less enigmatic: A survey of genetic counselors working in the somatic arena Dana Farengo-Clark
GGT 190 Utility of Adding Phenotypic Criteria Refinement to ACMG Guidelines Lauren Frank
GGT 191 The Potential Incorporation of Pharmacogenetic Testing into the Genetic Counseling Practice Zoey Freedman
GGT 192 A method to improve genetic diagnostic yield among patients suspected to have primary immunodeficiency Kim Gall
GGT 193 Genetic Counselors’ Decision-Making in the Utilization of Polygenic Risk Scores in Breast Cancer Clinical Care Rachel Gosselin
GGT 194 Participant Outcomes Following Return of Unanticipated Medically Actionable Findings Melissa Heller
GGT 195 Genome Sequencing and the Challenges of the Rare Diagnosis in the NICU Setting Laura Hendon
GGT 196 The Use of Functional Study in Investigating Variants of Uncertain Significance Jada Jackson
GGT 197 An evidence-based evaluation of guidelines criteria for condition inclusion on ECS panels: identifying a guidelines-compliant panel Katie Johansen Taber
GGT 198 Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletions in a large clinical cohort Katheryn Jones
GGT 199 Experiences and Preferences of the Amish and Mennonite Regarding Genetic Testing Torey Jordan
GGT 200 Correlation of Reported Family History and Identified Genomic Results in a State-Funded Population Screening Research Initiative Whitley V. Kelley
GGT 201 Two novel cases of biallelic variants in TARS2 presenting with hypotonia, psychomotor delay, cerebellar atrophy and microcephaly; Further evidence towards classification for a mitochondrial disease gene Megan Landsverk
GGT 202 Parental Impressions of Genetic Services for Individuals with Treacher Collins Syndrome Paige Ledford
GGT 203 Assessing Patient Attitudes Toward Pharmacogenetic Testing Grace Lee
GGT 204 Patient satisfaction with consumer-initiated pharmacogenetic testing and post-test telehealth genetic counseling. Jacquelyn Magner
GGT 205 Provider Thoughts and Opinions Towards Expanded Carrier Screening Derek Mann
GGT 206 Parental testing plays a significant role in clarification of uncertain genetic test results in the pediatric setting. Kati Mason, MS, CGC
GGT 207 Evaluating the Feasibility and Impact of Actively Requesting Clinical History at a Specialty Genetics Reference Laboratory Jamie McCreery
GGT 208 Genetic Counselors' Experiences and Current Practices Utilizing Clinically Available Breast Cancer Polygenic Risk Scores Molly McGuinness
GGT 209 Novel Screening for Advanced Paternal Age using Non-invasive Prenatal Testing for Single-Gene Disorders Pooja Mohan
GGT 210 Early Insights on Patient Engagement in a Bi-directional Network Informs Future Development of an Interactive Genome Management Platform Ana Morales
GGT 211 The Role of Allele-Specific RNA Analysis in Hereditary Cancer Variant Classification Erin Mundt
GGT 212 Carrier Screening for X-linked Conditions is Common Practice Dana Neitzel
GGT 213 Elucidating the phenotypic variability associated with the polyT tract in CFTR Keith Nykamp
GGT 214 Collaborative approach to clinical correlation and variant interpretation provides diagnosis for 2 brothers with KDM6A variant Emily H. Palen
GGT 215 Clinical outcomes of rare chromosomal abnormalities detected by a whole-genome non-invasive prenatal screening assay Sarah Paolucci
GGT 216 Creating a source of truth: The Sanford experience with centralizing genomic information in the medical record. Erin Royer
GGT 217 Prenatal theoretical diagnostic yield of a rapid, targeted genetic panel designed for critically ill pediatric patients. Danuta Stachiw-Hietpas
GGT 218 Molecular Testing for ADPKD in Pediatric and Adult Cohorts Reveals Increased Incidence of PKD1 Truncating Variants in the Pediatric Population Laura Sulmonte
GGT 219 Genetic Characterization of Shwachman Diamond Syndrome Ashley S. Thompson
GGT 220 Unblurring the ultrasound lines: 45% of infants with prenatal findings receive a reportable result on diagnostic exome sequencing Meghan Towne
GGT 221 Clinical outcomes of preimplantation genetic testing for hereditary cancer predisposition syndromes: A systematic review Natalie Vriesen
GGT 222 Detecting Novel SNVs and Indels in Alpha Thalassemia Carriers J. Sherry Wang
PED 223 Long-Term Outcomes of Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) Faria Ahmed
PED 224 Supplemental Newborn and Pediatric Screening: Insight into Consumers and Results Stephanie Ashley, MGC, CGC
PED 225 A recurrent DMD deletion in boys referred to genetics for cognitive and neurobehavioral disorders Miriam Bunch
PED 226 Exploring Mothers' Experiences with their Child's Diagnosis of Hypermobile Ehlers Danlos Syndrome Lauren DeMeyer
PED 227 Development of a Children's Book on Infertility and Family Planning for Girls with Turner Syndrome Aimee Durrett, MS, GC
PED 228 Parental Perceptions of Genetic Testing for Hearing Loss: Value and Impact Briana Feirstein
PED 229 Step by step: Diagnosis of rare mesoaxial synostotic syndactyly with phalangeal reduction following cascade testing in the pediatric genetics clinic Leslie Granger
PED 230 The Spectrum of Features in Males and Females with Mosaic 45,X +Y Lindsey Guzewicz
PED 231 The Economics of Genetic Disease in a Level IV NICU: Diagnostic Approaches and Cost of Care Leanne Hagen
PED 232 The Parental Perspective of Waiting for Pediatric Clinical Whole Exome Sequencing Results Stephanie Lucia
PED 234 Ultra-rare Diagnoses Highlighting the Importance of Variant of Uncertain Significance Interpretation Kari Magnussen
PED 235 Epistaxis and Telangiectasias: Hereditary Hemorrhagic Telangiectasia (HHT) compared to the General Population Jamie McDonald
PED 236 Open Operculum in Association with 22q11.2 Deletion Syndrome: An Underreported Diagnostic Biomarker Possibly Linked with Delay in Emergence of Language Jessica Merberg, MS
PED 237 Continuing a Search for a Diagnosis: Perspectives from Parents of Children with Undiagnosed Diseases Ilana Miller
PED 238 Anxiety, depression, and uncertainty impact quality of life in parents of children with a positive X-linked adrenoleukodystrophy newborn screen Kayla Muirhead
PED 239 An Unusual Presentation of Rubinstein-Taybi Syndrome: Genetic Counseling Challenges Megan Parker Fonville, MS, CGC
PED 240 Pitt-Hopkins syndrome: consider in the differential diagnosis in pediatric patients with global developmental delays Chana Ratner
PED 241 Expanding the Phenotype of Xia Gibbs Syndrome: A Case Report on Patient with a Novel ADHC1 Variant Kelly Roche
PED 242 Pediatric genetic counseling: a practice analysis and perspectives from pediatric genetic counselors - a consortium study Alyssa Sherwood
PED 243 Not alone anymore: parent and sibling experiences finding support with an ultra-rare diagnosis Kaitlin C. Smith
PED 244 Quality of Life of Children with Spinal Muscular Atrophy: Parents' Perspectives in Light of New Treatments Analyssa Tallas
PED 245 Novel Cranial Nerve VI Hypoplasia causing lateral rectus palsy with pathogenic variant in PPP1CB Kerry M White, MS, LCGC
PED 246 Assessing Interest in Genetic Counseling for Patients with Immune Deficiencies Victoria Willingham
PRE 247 Compound heterozygote for Tay Sachs and Sandhoff disease: implications for Tay Sachs carrier testing by enzyme analysis Alexandra Barbarese
PRE 248 Factors that Impact Uptake of Carrier Screening in Males Wendi Betting
PRE 249 Exploring Factors that Influence Reproductive Decision-Making in Duchenne Muscular Dystrophy Carriers Caroline Bong
PRE 250 Parental Questions About Sex Chromosome Aneuploidies Regarding Sex, Gender, and Sexual Orientation in a Prenatal Setting Sarah Burzynski, MS
PRE 251 The Impact of Genetic Counseling on Patient Uptake and Satisfaction of Preimplantation Genetic Testing Alexis Coates
PRE 252 Enhancement of spinal muscular atrophy carrier screening with unique variants: to include or not to include? Linda Cheng
PRE 253 Mosaic Trisomy 13 Detected by Cell-Free DNA: Important Counseling Considerations for a Variable Phenotype Nicole Choy
PRE 254 Utilization of Expanded Carrier Screening by Reproductive Genetic Counselors Emily Collins
PRE 255 The Impact of Abortion Laws on Prenatal Genetic Counseling: A Comparison Between States Casey Crawford, MS
PRE 256 Non-Invasive Prenatal Screening Results Suggestive of Maternal Malignancy: The Genetic Counselor's Experience Taylor Durant
PRE 257 Using invasive testing rates and pregnancy outcomes to guide genetic counseling for patients who receive a failed cell-free fetal DNA screening. Jennifer Dykeman
PRE 258 Diagnostic testing trends after genome-wide cell-free DNA prenatal screening results Kimberly Fanelli
PRE 259 Physician Opinions on Mosaicism in Preimplantation Genetic Screening and Genetic Counseling Irene Ford
PRE 260 Knowledge, perceptions, and current trends in carrier screening among Orthodox Jewish young adults Yoheved Gerstein
PRE 261 Challenges in genetic counseling for renal anomalies Ping Gong
PRE 262 Exploring the benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals found to have an increased reproductive risk Melanie Hardy
PRE 263 Experiences of prenatal genetic counselors with abortion regulations in Ohio Anne Heuerman
PRE 264 Family Communication of Genetic Results Found on Expanded Carrier Screening Haley Hill, MS
PRE 265 Cell free DNA screening for copy number variants secures a diagnosis of Wolf-Hirschhorn syndrome in a pregnancy with suspected anomalies Natalie Jacob
PRE 266 Female and Male Perspectives on the Involvement of Male Partners in Expanded Carrier Screening Sarah Jurgensmeyer
PRE 267 A Familial Xq Deletion/Duplication Ascertained Incidentally via Sequencing-Based Expanded Carrier Screening Olga Latosh
PRE 268 Prenatal Diagnosis of Swyer Syndrome due to Discordance Between cfDNA and Fetal Ultrasound Enrique Lopez
PRE 269 Reporting and Transfer of Mosaic Embryos: Experiences and Attitudes of Genetic Counselors Casey Marks
PRE 270 Prenatal ascertainment of Bardet Biedl syndrome that was missed by expanded carrier screening Erin McGraw
PRE 271 Pregnancy, Genetic Counseling and Cystic Fibrosis: Exploring the experiences and discussions between females with CF and their health care providers. Morgan McManus
PRE 272 Assessing Social Media for Themes of Trisomy 18 and 13 Falecia Metcalf
PRE 273 Omphalocele and monosomy X: expanding the phenotype of 45,X through first trimester ultrasound Kristen Miller
PRE 275 Expanded Carrier Screening allowed Prenatal Diagnosis of Congenital Finnish Nephrosis without Diagnostic Testing Alexis Morgan
PRE 276 Prenatal diagnosis of mosaic 45,X/46,X,idic(Y) after discordant findings from cell free DNA and prenatal ultrasound: A case series Lauren Petrarca
PRE 277 The Emotional Impact of Restrictive Abortion Laws on Prenatal Genetic Counselors Elizabeth Pollard
PRE 278 Genetic counseling on road to a complex familial diagnosis: A lethal ciliopathy. Nivedita Rajakumar
PRE 279 Genetic counselors’ experiences with transgender individuals in prenatal and preconception settings Maggie Ruderman
PRE 280 Diagnostic Testing Uptake Rates in Fragile X Premutation Carriers and Couples At Risk for an Autosomal Recessive Condition in Their Offspring Kendall Snyder
PRE 281 “Desbu-what?”: Rare diagnosis highlights limitations of ultrasound parameters suggestive of lethal skeletal dysplasia Samantha Stover
PRE 282 Prenatal Genetic Testing Decisions After In Vitro Fertilization with Preimplantation Genetic Testing Marina Sumarroca
PRE 283 Patient Knowledge of, Attitudes Toward, and Perceived Utility of Carrier Screening in an Obstetric Setting Rachel Thomas
PRE 284 Noninvasive Prenatal Screening For Copy Number Variants: Opinions and Current Use By Prenatal Genetic Counselors Kara Vitalone
PRE 285 Biallelic variants in MYMK as a novel cause of recurrent cystic hygroma and early fetal hydrops in two consecutive pregnancies: Phenotypic expansion of Carey-Fineman-Ziter syndrome Lauren Westerfield
PRE 286 Revisiting the Essential Informational Needs of Parents Receiving a Diagnosis of Down Syndrome Margaret Wilkes
PRE 287 NGS Panel Testing in the Prenatal Diagnosis of RASopathies in Fetuses with Abnormal Ultrasound Findings Bradley Williams
PI 288 Tracking and Management of Variants of Uncertain Significance in Clinics Over Time Elise Bergin
PI 289 Techniques to Facilitate Communication Among Racially And Ethnically Isolated Genetic Professionals Austin Bland
PI 290 Career Ladder Development: Insights and Experiences from Both Clinical and Industry Genetic Counselors Hayley Bottino
PI 291 A National Sampling of Characteristics of a Genetic Counselor Career Ladder Hayley Bottino
PI 292 Exploring the Integration of Adverse Childhood Experiences in Genetic Counseling Practice Hannah Brodner
PI 293 GCs become established in a new position in 4 months, as indicated by decreases in documentation time Colleen Caleshu
PI 294 Peer-Reviewed Outcomes and Perceptions of Genetic Counseling Student Research Caitlin Clark-Wiest
PI 295 Exploring Genetic Counselors’ Perceptions and Attitudes Towards Preimplantation Genetic Testing for Aneuploidy (PGT-A) Danika Coulson
PI 296 An Academic RVU for Genetic Counselors: Development of a Tool to Measure Productivity Sandra Darilek
PI 297 Misinterpretation of Genetic Test Results by Healthcare Providers Katherine Donohue
PI 298 An Exploration of Genetic Counselors’ Use and Application of Family Health History Tools Pankti Doshi
PI 299 Bridging the Gap between Genetic Counselors and Special Education: A Survey on Genetic Counselors' Knowledge and Attitudes Rosetta Dowling
PI 300 Improving Access to Potential Genetic Counseling Students through High School Counselors Summer Duffy
PI 301 Genetic Counseling Job Search: Facilitators and Barriers Sierra Dyer
PI 302 Does Experience Matter? An Examination of the Factors Influencing Application and Acceptance of Jobs by Genetic Counselors Sierra Dyer
PI 303 Laboratory Genetic Counselors’ Motivations for Choosing this Practice Specialty: A Qualitative Investigation Maribeth Golm
PI 304 Investigating the Factors That Affect Providers’ Discussion of Pre-Implantation Genetic Testing for Adult-Onset Hereditary Cancer Syndromes in Gene Positive Patients Ashley Kennes
PI 305 The “Floating GCA”: Introducing a Multidisciplinary Genetic Counseling Assistant in an Academic Hospital Courtney E. Leonard
PI 306 : Involvement of Genetic Counselors at State-Level Association in Pennsylvania Claire Nelson
PI 307 Exploring the experience of reapplying for admission to genetic counseling programs after initial rejection Gabrielle Pomorski
PI 309 Defining the Roles of Laboratory Genetic Counseling Assistants and Important Factors in the Genetic Counselor – Genetic Counseling Assistant (GC-GCA) Relationship Jordyn Prell
PI 310 How Genetic Counselors Remain Informed of Practice Guidelines. Samantha Sandlow
PI 311 Geographical Analysis of the Distribution of Certified Genetic Counselors in the United States Karina Skov
PI 313 Outcomes of a Genetic Counseling Assistant Mentorship Program Elise Watson
PI 314 Perceived Value of Genetic Counseling for Consumer-Initiated Genetic Testing Nori Williams, CGC
PI 315 Life Outside Clinic: The Lived Experiences and Family Planning Decisions of Genetic Counselors Working with Pediatric Patients Kristen Wong
PI 316 Diverse Career Considerations of Potential Genetic Counseling Applicants Rachel Wyatt
NEU 317 Presenting Features and the Availability of Parental Testing Strongly Influence Diagnostic Rates of Multi-Gene Panels for Brain Malformation Disorders Sohnee Ahmed
NEU 318 Characterization of Depressive Symptoms in Individuals with Reduced Penetrance Huntington’s Disease Allele Expansions using Enroll-HD Christina Dailey
NEU 320 Nuclear localization of ATXN1 in extra-cerebellar SCA1 pathology Hillary Handler
NEU 321 Perceptions of Social Rejection and Fear in Individuals with Mosaic Down Syndrome Quinn Hurshman
NEU 322 The ALS Genetic Access Program: Paving the Way for Genetic Testing, Counseling and Therapy for ALS Jennifer Roggenbuck
NEU 323 An Investigation into the reasons behind quality of life perception in individuals with HNPP as compared to individuals with CMT1A Caitlin Walsh
PH 324 Insurance Coverage Impacts the Clinical Use of Prenatal Chromosomal Aneuploidy Screening: Implications for Health Equity Megan Benoy
PH 325 Estimating the need for and utilization of allogeneic hematopoietic cell transplantation (alloHCT) to treat severe combined immunodeficiency (SCID) Anna DeSalvo, MS, CGC
PH 326 Patient Navigators vs. Electronic Medical Record Messaging: Genetic counseling appointment completion in an underserved population Amber Gemmell
PH 327 Assessment of Cancer Risk Understanding and Motivations of Individuals Receiving Negative Screening Results in the Healthy Oregon Project Emily Guilbert
PH 328 Primary Care for Rare Disease Patients: Exploring services received, healthcare providers involved, and patient satisfaction Catherine Mayo
PH 329 Tower of Babel: A Qualitative Cross-Site Comparison of Provider Terminology when Discussing Universal Lynch Syndrome Screening Zachary Salvati
RI 330 Attitudes About Data Sharing in Parent and Adolescent Participants in a Pediatric Genomic Research Repository Courtney Berrios
RI 331 What is ‘Usual Care’ in Genetic Counseling Research? Evidence from CSER Consortium Studies Barbara Biesecker
RI 332 Biobank set-up and execution: A retrospective effort analysis Carrie Blout
RI 333 Developing a framework for performing genotype-phenotype analyses using a real-world data platform Kristina Cotter
RI 334 The Million Veteran Program - Return Of Actionable Results (MVP-ROAR) Study: Design and Pilot Results Morgan Danowski
RI 335 Variant reclassifications at the intersection of research and clinical care Emma Perez
RI 336 Spatial and nonspatial barriers to Undiagnosed Diseases Network acceptance: Implications for accessing research Gianna Petrelli
RI 337 Declining medically actionable genetic results: Why Mass General Brigham Biobank participants opt out of clinical result confirmation Janelle Shea, BS, BA
UM 338 Work Smarter, Not Harder: Use of a Dynamic Database to Streamline Test Utilization Management Sarah Arneson
UM 339 Implementation and Cost Savings of Optional Pre-authorization at a Large Pediatric Institution Kathleen Collins Ruff
UM 340 Implementation of genetic carrier screening in the OB population: healthcare cost impact and recommendation adherence Aranza Gonzalez Cendejas
UM 341 Current hereditary cancer reflex testing practices for Ashkenazi Jewish individuals, a large commercial laboratory’s experience Mary Hricik
UM 342 Assessing the Impact of a Genetic Counseling Assistant at a Hematology Reference Laboratory Stefanie Dugan, MS, CGC
UM 343 Genetic Counselors’ Involvement and Perceived Impact in the IEP and 504 School Accommodations Process Kaitlin Oconnell
UM 344 Assessing The Current Landscape of National Payer Policy Regarding Genetic Counseling Services and Billing Practices Eric Tricou
UM 345 Laboratory Genetic Counseling Assistant Adds Value to a Genetic Test Stewardship Program Claire Wittowski
CAN 346 A Variant in the PMS2 Gene versus PMSCL pseudogene in a Patient with Prostate Cancer: Implications for Patient Counseling and Additional Testing Amanda Schott
NSGC Executive Office   |   330 North Wabash Avenue, Suite 2000, Chicago, IL 60611   |   312.321.6834   |
© 2021 National Society of Genetic Counselors   |   Privacy Policy   |   Disclaimer   |   Terms and Conditions   |   DMCA Procedures for Removal